Skip to main content

EDITORIAL article

Front. Cardiovasc. Med.
Sec. Cardiovascular Pharmacology and Drug Discovery
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1468355
This article is part of the Research Topic Nutraceuticals in Cardiovascular Diseases and their Associated Risk Conditions View all 10 articles

Editorial: Nutraceuticals in Cardiovascular Diseases and their Associated Risk Conditions

Provisionally accepted
Lamiaa A. Ahmed Lamiaa A. Ahmed 1*Naufal Zagidullin Naufal Zagidullin 2
  • 1 Faculty of Pharmacy, Cairo University, Giza, Egypt
  • 2 Bashkir State Medical University, Ufa, Bashkortostan, Russia

The final, formatted version of the article will be published soon.

    Keywords: Cardiovascular Diseases, Inflammation, Nutraceuticals, Oxidative Stress, Comorbidity, Cardioprotection

    Received: 21 Jul 2024; Accepted: 27 Aug 2024.

    Copyright: © 2024 Ahmed and Zagidullin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Lamiaa A. Ahmed, Faculty of Pharmacy, Cairo University, Giza, Egypt

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.